首页> 美国卫生研究院文献>Virus Evolution >A16 Next-generation sequencing to detect transmitted drug resistance mutations in Romanian people who inject drugs
【2h】

A16 Next-generation sequencing to detect transmitted drug resistance mutations in Romanian people who inject drugs

机译:A16下一代测序可检测罗马尼亚注射毒品人群中传播的耐药性突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Romania has faced an HIV outbreak among people who inject drugs (PWID) since 2011. The introduction of so-called ‘legal highs’ (amphetamine-type stimulants) on the drug market a few years prior contributed substantially to this outbreak. Next-generation sequencing (NGS) provides the possibility to detect drug resistance mutations with higher sensitivity than Sanger sequencing. The aim of this study was to search for transmitted drug resistance (TDR) mutations in strains from PWID recently diagnosed with HIV infection by parallel use of Sanger sequencing and NGS. The study was conducted on strains from 34 PWID diagnosed with HIV infection between 2016 and 2017. Sequencing was performed for the pol (PR, RT, and INT) and env (V2-V3 loop) regions. Sanger sequencing was performed with the commercial ViroseqTMHIV-1 Genotyping system (Abbott Laboratories) and with an in-house protocol for the env gene. NGS was performed in the same genomic regions using Nextera DNA Library Preparation Kit (Illumina) and the Miseq instrument (Illumina). NGS data were processed for error correction, read mapping, and detection of drug resistance mutations with HIV-1 Deepchek analysis software. Geno2pheno algorithm was used for viral tropism prediction and the WHO 2009 list for TDRM analysis. By using NGS, we detected seven cases (20.6%) of TDR in PWID and only two cases (5.8%) with standard sequencing. The TDR mutations detected by NGS were K103N, K101EN, Y181C, T215S in RT gene, I54V and M46L in PR, and none in INT. Two NNRTI mutations (K103N and K101EN) were detected in the same sample. Most of the TDR identified were present in the minority population (between 1% and 2% of the total reads) explaining the higher sensitivity of NGS method compared with standard sequencing. No significant differences were observed between these two methods when tropism prediction was analyzed. The majority of the viruses circulating in this group were R5-tropic. All strains showed more resistance mutations when analyzed by deep sequencing than by Sanger sequencing and more than previously observed in other risk groups. NGS proved to be a sensitive tool to detect TDR in newly infected PWID.
机译:自2011年以来,罗马尼亚就在注射毒品的人群中爆发了艾滋病毒爆发。几年前,在毒品市场上引入了所谓的“合法高潮”(安非他明类兴奋剂),对这一爆发起到了重要作用。下一代测序(NGS)提供了比Sanger测序更高灵敏度检测耐药性突变的可能性。这项研究的目的是通过并行使用Sanger测序和NGS在最近被诊断出感染HIV的PWID菌株中寻找传播的耐药性(TDR)突变。该研究针对2016年至2017年间被确诊为HIV感染的34个PWID菌株进行。对pol(PR,RT和INT)和env(V2-V3环)区域进行了测序。用商业ViroseqTMHIV-1基因分型系统(Abbott Laboratories)和env基因的内部操作规程进行Sanger测序。使用Nextera DNA库制备试剂盒(Illumina)和Miseq仪器(Illumina)在相同的基因组区域进行NGS。使用HIV-1 Deepchek分析软件对NGS数据进行了错误校正,读取映射和耐药性突变检测。 Geno2pheno算法用于病毒的向性预测,WHO 2009列表用于TDRM分析。通过使用NGS,我们检测到7例(20.6%)的TWID在PWID中,只有2例(5.8%)进行了标准测序。 NGS检测到的TDR突变为RT基因中的K103N,K101EN,Y181C,T215S,PR中的I54V和M46L,而INT中无。在同一样本中检测到两个NNRTI突变(K103N和K101EN)。鉴定出的大多数TDR存在于少数人群中(占总读数的1%至2%),这说明与标准测序相比,NGS方法具有更高的灵敏度。分析向性性预测时,这两种方法之间没有观察到显着差异。该组中传播的大多数病毒是R5嗜性的。当通过深度测序进行分析时,所有菌株均显示出比Sanger测序更多的抗性突变,并且比以前在其他风险组中观察到的更多。 NGS被证明是检测新感染PWID中TDR的敏感工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号